Caspase-11: Arming the guards against bacterial infection

Immunological Reviews

Volumn 265, Issue 1, 2015, Pages 75-84

  Stowe, Irma ^a   Lee, Bettina ^a   Kayagaki, Nobuhiko ^a  

^a GENENTECH INC   (United States)

Author keywords

Bacterial disease; Endotoxin shock; Lipopolysaccharide

Indexed keywords

CASPASE 11; CASPASE 4; CASPASE 5; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; CASP11 PROTEIN, MOUSE; CASP4 PROTEIN, HUMAN; CASPASE; INITIATOR CASPASE; MULTIPROTEIN COMPLEX;

BACTERIAL INFECTION; CELL VACUOLE; CELLS BY BODY ANATOMY; CHEMISTRY; ENZYME ACTIVATION; EPITHELIUM CELL; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MOLECULAR RECOGNITION; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEPSIS; TISSUE INJURY; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; BACTERIAL INFECTIONS; CASPASES; CASPASES, INITIATOR; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MICE; MULTIPROTEIN COMPLEXES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84927732727     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12292     Document Type: Review

References (92)

1. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-574.
2. Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 2002;9:358-361.
3. Thornberry NA, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992;356:768-774.
4. Thornberry NA. Caspases: a decade of death research. Cell Death Differ 1999;6:1023-1027.
5. Broz P, von Moltke J, Jones JW, Vance RE, Monack DM. Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 2010;8:471-483.
6. Eder C. Mechanisms of interleukin-1beta release. Immunobiology 2009;214:543-553.
7. Piccioli P, Rubartelli A. The secretion of IL-1beta and options for release. Semin Immunol 2013;25:425-429.
8. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993;75:641-652.
9. Wang S, et al. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J Biol Chem 1996;271:20580-20587.
10. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998;92:501-509.
11. Faucheu C, et al. A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 1995;14:1914-1922.
12. Munday NA, et al. Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 1995;270:15870-15876.
13. Kamens J, et al. Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 1995;270:15250-15256.
14. Faucheu C, Blanchet AM, Collard-Dutilleul V, Lalanne JL, Diu-Hercend A. Identification of a cysteine protease closely related to interleukin-1 beta-converting enzyme. Eur J Biochem 1996;236:207-213.
15. Van de Craen M, et al. Characterization of seven murine caspase family members. FEBS Lett 1997;403:61-69.
16. Sakamaki K, Satou Y. Caspases: evolutionary aspects of their functions in vertebrates. J Fish Biol 2009;74:727-753.
17. Kuida K, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995;267:2000-2003.
18. Li P, et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995;80:401-411.
19. Kayagaki N, et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011;479:117-121.
20. Kang SJ, et al. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 2000;149:613-622.
21. Kenneth NS, et al. An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1. Biochem J 2012;443:355-359.
22. Vanden Berghe T, et al. An inactivating caspase-11 passenger mutation muddles sepsis research. Am J Respir Crit Care Med 2013;188:120-121.
23. Keane TM, et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 2011;477:289-294.
24. Guan C, Ye C, Yang X, Gao J. A review of current large-scale mouse knockout efforts. Genesis 2010;48:73-85.
25. Eisener-Dorman AF, Lawrence DA, Bolivar VJ. Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun 2009;23:318-324.
26. Lusis AJ, Yu J, Wang SS. The problem of passenger genes in transgenic mice. Arterioscler Thromb Vasc Biol 2007;27:2100-2103.
27. Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011;11:213-220.
28. Brodsky IE, Medzhitov R. Pyroptosis: macrophage suicide exposes hidden invaders. Curr Biol 2011;21:R72-R75.
29. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011;243:206-214.
30. Cunha LD, Zamboni DS. Subversion of inflammasome activation and pyroptosis by pathogenic bacteria. Front Cell Infect Microbiol 2013;3:76.
31. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014;15:135-147.
32. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-820.
33. Medzhitov R, et al. Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol 2011;11:693-702.
34. Ferrandon D, Imler JL, Hetru C, Hoffmann JA. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Nat Rev Immunol 2007;7:862-874.
35. Moresco EM, LaVine D, Beutler B. Toll-like receptors. Curr Biol 2011;21:R488-R493.
36. Mariathasan S, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004;430:213-218.
37. Mariathasan S, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006;440:228-232.
38. Kanneganti TD, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006;440:233-236.
39. Zhao Y, et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011;477:596-600.
40. Kofoed EM, Vance RE. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011;477:592-595.
41. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009;458:509-513.
42. Hornung V, et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009;458:514-518.
43. Xu H, et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 2014;513:237-241.
44. Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-832.
45. Jin C, Flavell RA. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 2010;30:628-631.
46. Franchi L, Warner N, Viani K, Nunez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009;227:106-128.
47. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117:3720-3732.
48. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol 2012;13:333-342.
49. Wen H, Miao EA, Ting JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013;39:432-441.
50. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014;157:1013-1022.
51. Gurung P, et al. Toll or interleukin-1 receptor (TIR) domain-containing adaptor inducing interferon-beta (TRIF)-mediated caspase-11 protease production integrates Toll-like receptor 4 (TLR4) protein- and Nlrp3 inflammasome-mediated host defense against enteropathogens. J Biol Chem 2012;287:34474-34483.
52. Rathinam VA, et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 2012;150:606-619.
53. Broz P, et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 2012;490:288-291.
54. Case CL, et al. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proc Natl Acad Sci USA 2013;110:1851-1856.
55. Aachoui Y, et al. Caspase-11 protects against bacteria that escape the vacuole. Science 2013;339:975-978.
56. Knodler LA, et al. Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 2014;16:249-256.
57. Kayagaki N, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013;341:1246-1249.
58. Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 2013;341:1250-1253.
59. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635-700.
60. Poltorak A, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
61. Takeuchi O, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-451.
62. Raetz CR, Reynolds CM, Trent MS, Bishop RE. Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem 2007;76:295-329.
63. Ogawa T, et al. Endotoxic and immunobiological activities of a chemically synthesized lipid A of Helicobacter pylori strain 206-1. FEMS Immunol Med Microbiol 2003;36:1-7.
64. Moran AP, Lindner B, Walsh EJ. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J Bacteriol 1997;179:6453-6463.
65. Zhong Z, et al. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun 2013;4:1611. doi:10.1038/ncomms2608.
66. Hayashi F, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-1103.
67. Franchi L, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 2006;7:576-582.
68. Miao EA, et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 2006;7:569-575.
69. Beddoe T, Paton AW, Le Nours J, Rossjohn J, Paton JC. Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci 2010;35:411-418.
70. Gupta RK, Egan W, Bryla DA, Robbins JB, Szu SC. Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes. Infect Immun 1995;63:2805-2810.
71. Ray K, Marteyn B, Sansonetti PJ, Tang CM. Life on the inside: the intracellular lifestyle of cytosolic bacteria. Nat Rev Microbiol. 2009;7:333-340. doi:10.1038/nrmicro2112.
72. Mariathasan S. ASC, Ipaf and Cryopyrin/Nalp3: bona fide intracellular adapters of the caspase-1 inflammasome. Microbes Infect 2007;9:664-671.
73. Bauernfeind FG, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009;183:787-791.
74. Schauvliege R, Vanrobaeys J, Schotte P, Beyaert R. Caspase-11 gene expression in response to lipopolysaccharide and interferon-gamma requires nuclear factor-kappa B and signal transducer and activator of transcription (STAT) 1. J Biol Chem 2002;277:41624-41630.
75. Kajiwara Y, et al. A critical role for human caspase-4 in endotoxin sensitivity. J Immunol 2014;193:335-343.
76. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417-426.
77. Wickliffe KE, Leppla SH, Moayeri M. Anthrax lethal toxin-induced inflammasome formation and caspase-1 activation are late events dependent on ion fluxes and the proteasome. Cell Microbiol 2008;10:332-343.
78. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006;38:240-244.
79. Pilla DM, et al. Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. Proc Natl Acad Sci USA 2014;111:6046-6051.
80. Meunier E, et al. Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. Nature 2014;509:366-370.
81. MacMicking JD. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 2004;25:601-609.
82. Lamkanfi M, et al. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 2010;185:4385-4392.
83. Vanden Berghe T, et al. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med 2014;189:282-291.
84. Lin XY, Choi MS, Porter AG. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J Biol Chem 2000;275:39920-39926.
85. Kobayashi T, et al. The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection. Cell Host Microbe 2013;13:570-583.
86. Shi J, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 2014;514:187-192.
87. Sollberger G, Strittmatter GE, Kistowska M, French LE, Beer HD. Caspase-4 is required for activation of inflammasomes. J Immunol 2012;188:1992-2000.
88. Thornberry NA, et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997;272:17907-17911.
89. Kersse K, Verspurten J, Vanden Berghe T, Vandenabeele P. The death-fold superfamily of homotypic interaction motifs. Trends Biochem Sci 2011;36:541-552.
90. Huang W, et al. Mechanistic insights into CED-4-mediated activation of CED-3. Genes Dev 2013;27:2039-2048.
91. Iwanaga S, Lee BL. Recent advances in the innate immunity of invertebrate animals. J Biochem Mol Biol 2005;38:128-150.
92. Salzet M. Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. Trends Immunol 2001;22:285-288.